HerceptinRaloxifene5-FluorouracilIn-situCarcinomaMultifocalTumorsWomen ages40+ shouldhave a clinicalbreast examat least yearlyEGFR(epidermalgrowth factorreceptor)MethotrexatePARPInhibitorsFibroadenomaExcisionalBiopsyBilateralProphylacticMastectomyLymphoscintigraphyAnastrozolePalbociclibAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerKi-67RateGeneMutationDoseDenseTherapyLumpectomyAdvocacyInvasiveBreastCancerLCISBOCATyrosine-KinaseInhibitorSclerosingAdenosisDoxorubicinKappaEpsilonAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenCalcificationsPI3KinaseInhibitorsWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.BRCAGeneDisease-FreeSurvivalRateMorpheaMetastaticBreastCancerGenomicTestinglatissimusflapBevacizumabMastitisMastodyniaPagetDiseaseBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55EndometrialCancerProgestinAromataseInhibitorsEstradiolNeoplasmBenignPhyllodesTumorHormoneReplacementTherapyDocetaxelNodeNegativeCAMDefinitiveSurgeryAngiogenesisGailModelAdjuvantTherapyEstrogenAdenocarcinomaRADAxillarySamplingBiopsyStagingAlopeciaCytostaticBreastTomosynthesisAntiemeticCMFChemotherapyDimplingTripleNegativeBreastCancerFISHBI-RADSCyclophosphamideBreastCancerER+Co-survivorGeneticPredispositionHormoneReceptorStatusImmunotherapyFlowCytometryCystECOGScoreBrachytherapyNodePositivePrecisionMedicineAyurvedaDiabeticMastopathyChemopreventionOvarianSuppressionLapatinibCachexiaGermlineMutationPhyllodesTumorTamoxifenLumpAbsoluteRiskHER-2GeneticCounselingCytotoxicFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.OligometastasesMultimodalityTherapyRelapseEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearSERM1 in 8womenCapecitabineFamilyHistoryLiquidBiopsyPaclitaxelAntibodyTherapyMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltMolecularBreastImagingCheckpointInhibitormTORInhibitorsEvidencesuggests thatphysical activitymay reduce therisk of breastcancersChemotherapyMetastasisTriplePositiveBreastCancerGuaranteedRenewableInsuranceDown-StagingCDK4/6InhibitorsNeoadjuvantTherapyPathologicResponseRadiotherapyOophorectomySelf-examinationMastectomyER-MastalgiaTumorGradeIntraductalPapillomaLymphNodeStatusMegestrolAcetateApoptosisPalpationACChemotherapyMRIHerceptinRaloxifene5-FluorouracilIn-situCarcinomaMultifocalTumorsWomen ages40+ shouldhave a clinicalbreast examat least yearlyEGFR(epidermalgrowth factorreceptor)MethotrexatePARPInhibitorsFibroadenomaExcisionalBiopsyBilateralProphylacticMastectomyLymphoscintigraphyAnastrozolePalbociclibAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerKi-67RateGeneMutationDoseDenseTherapyLumpectomyAdvocacyInvasiveBreastCancerLCISBOCATyrosine-KinaseInhibitorSclerosingAdenosisDoxorubicinKappaEpsilonAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenCalcificationsPI3KinaseInhibitorsWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.BRCAGeneDisease-FreeSurvivalRateMorpheaMetastaticBreastCancerGenomicTestinglatissimusflapBevacizumabMastitisMastodyniaPagetDiseaseBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55EndometrialCancerProgestinAromataseInhibitorsEstradiolNeoplasmBenignPhyllodesTumorHormoneReplacementTherapyDocetaxelNodeNegativeCAMDefinitiveSurgeryAngiogenesisGailModelAdjuvantTherapyEstrogenAdenocarcinomaRADAxillarySamplingBiopsyStagingAlopeciaCytostaticBreastTomosynthesisAntiemeticCMFChemotherapyDimplingTripleNegativeBreastCancerFISHBI-RADSCyclophosphamideBreastCancerER+Co-survivorGeneticPredispositionHormoneReceptorStatusImmunotherapyFlowCytometryCystECOGScoreBrachytherapyNodePositivePrecisionMedicineAyurvedaDiabeticMastopathyChemopreventionOvarianSuppressionLapatinibCachexiaGermlineMutationPhyllodesTumorTamoxifenLumpAbsoluteRiskHER-2GeneticCounselingCytotoxicFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.OligometastasesMultimodalityTherapyRelapseEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearSERM1 in 8womenCapecitabineFamilyHistoryLiquidBiopsyPaclitaxelAntibodyTherapyMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltMolecularBreastImagingCheckpointInhibitormTORInhibitorsEvidencesuggests thatphysical activitymay reduce therisk of breastcancersChemotherapyMetastasisTriplePositiveBreastCancerGuaranteedRenewableInsuranceDown-StagingCDK4/6InhibitorsNeoadjuvantTherapyPathologicResponseRadiotherapyOophorectomySelf-examinationMastectomyER-MastalgiaTumorGradeIntraductalPapillomaLymphNodeStatusMegestrolAcetateApoptosisPalpationACChemotherapyMRI

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
  1. Herceptin
  2. Raloxifene
  3. 5-Fluorouracil
  4. In-situ Carcinoma
  5. Multifocal Tumors
  6. Women ages 40+ should have a clinical breast exam at least yearly
  7. EGFR (epidermal growth factor receptor)
  8. Methotrexate
  9. PARP Inhibitors
  10. Fibroadenoma
  11. Excisional Biopsy
  12. Bilateral Prophylactic Mastectomy
  13. Lymphoscintigraphy
  14. Anastrozole
  15. Palbociclib
  16. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  17. Ki-67 Rate
  18. Gene Mutation
  19. Dose Dense Therapy
  20. Lumpectomy
  21. Advocacy
  22. Invasive Breast Cancer
  23. LCIS
  24. BOCA
  25. Tyrosine-Kinase Inhibitor
  26. Sclerosing Adenosis
  27. Doxorubicin
  28. Kappa Epsilon
  29. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  30. Calcifications
  31. PI3 Kinase Inhibitors
  32. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  33. BRCA Gene
  34. Disease-Free Survival Rate
  35. Morphea
  36. Metastatic Breast Cancer
  37. Genomic Testing
  38. latissimus flap
  39. Bevacizumab
  40. Mastitis
  41. Mastodynia
  42. Paget Disease
  43. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  44. Endometrial Cancer
  45. Progestin
  46. Aromatase Inhibitors
  47. Estradiol
  48. Neoplasm
  49. Benign Phyllodes Tumor
  50. Hormone Replacement Therapy
  51. Docetaxel
  52. Node Negative
  53. CAM
  54. Definitive Surgery
  55. Angiogenesis
  56. Gail Model
  57. Adjuvant Therapy
  58. Estrogen
  59. Adenocarcinoma
  60. RAD
  61. Axillary Sampling
  62. Biopsy
  63. Staging
  64. Alopecia
  65. Cytostatic
  66. Breast Tomosynthesis
  67. Antiemetic
  68. CMF Chemotherapy
  69. Dimpling
  70. Triple Negative Breast Cancer
  71. FISH
  72. BI-RADS
  73. Cyclophosphamide
  74. Breast Cancer
  75. ER+
  76. Co-survivor
  77. Genetic Predisposition
  78. Hormone Receptor Status
  79. Immunotherapy
  80. Flow Cytometry
  81. Cyst
  82. ECOG Score
  83. Brachytherapy
  84. Node Positive
  85. Precision Medicine
  86. Ayurveda
  87. Diabetic Mastopathy
  88. Chemoprevention
  89. Ovarian Suppression
  90. Lapatinib
  91. Cachexia
  92. Germline Mutation
  93. Phyllodes Tumor
  94. Tamoxifen
  95. Lump
  96. Absolute Risk
  97. HER-2
  98. Genetic Counseling
  99. Cytotoxic
  100. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  101. Oligometastases
  102. Multimodality Therapy
  103. Relapse
  104. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  105. SERM
  106. 1 in 8 women
  107. Capecitabine
  108. Family History
  109. Liquid Biopsy
  110. Paclitaxel
  111. Antibody Therapy
  112. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  113. Molecular Breast Imaging
  114. Checkpoint Inhibitor
  115. mTOR Inhibitors
  116. Evidence suggests that physical activity may reduce the risk of breast cancers
  117. Chemotherapy
  118. Metastasis
  119. Triple Positive Breast Cancer
  120. Guaranteed Renewable Insurance
  121. Down-Staging
  122. CDK4/6 Inhibitors
  123. Neoadjuvant Therapy
  124. Pathologic Response
  125. Radiotherapy
  126. Oophorectomy
  127. Self-examination
  128. Mastectomy
  129. ER-
  130. Mastalgia
  131. Tumor Grade
  132. Intraductal Papilloma
  133. Lymph Node Status
  134. Megestrol Acetate
  135. Apoptosis
  136. Palpation
  137. AC Chemotherapy
  138. MRI